Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response After Systemic Therapy: A Multicenter, Real-World Study

NCT07290764 is registered in ClinicalTrials.gov with Fujian Provincial Hospital as lead sponsor.

NCT NCT07290764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response After Systemic Therapy: A Multicenter, Real-World Study
Lead sponsor
Fujian Provincial Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2025
Completion date
June 1, 2026
Enrollment
729 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma